IUCT Oncopole — Toulouse

Public research footprint of IUCT Oncopole, compiled from the ClinicalTrials.gov public registry.

254

Registered studies

141

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Chronic Lymphocytic Leukemia · Relapsed/Refractory Peripheral T-Cell Lymphoma · Platinum-resistant Ovarian Cancer · Solid Tumor, Adult

Recently updated registry entries

NCT07106632 — Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent… (Recruiting)
NCT07739459 — Study of Zanubrutinib in Older Patients With Previously Untreated Chronic Lymphocytic… (Not Yet Recruiting)
NCT07738887 — Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia… (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at IUCT Oncopole?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.